1. |
Wang BE, Zhang DF, editor-in-chief. Modern study of liver disease. 1rst edition. BeiJing: Science Press, 2003. p. 513.
|
2. |
Luo KX, editor in chief. Hepatitis B - basic and clinical. 1rst edition. BeiJing: People’s Health Press, 1997, p. 370.
|
3. |
Lang JM, editor in chief. Clinical Immunology diagnosis. 1rst edition. GuangZhou: Guangdong Science and Technology Press, 2003, p. 61.
|
4. |
Wang BE. Current trends in the study of liver fibrosis. Chinese magazine liver disease, 2006, 14(3): 167-168.
|
5. |
May 1995, the Fifth National Conference on parasitic diseases discuss infectious diseases. Viral hepatitis Control Program (Tentative) . Chinese Journal of Infectious Diseases, 1995, 13(4): 241-247.
|
6. |
Xian. the Chinese Medical Association in September 2000 credits infectious and parasitic diseases, liver diseases jointly amend credit. Viral hepatitis Control Program (Tentative). Chinese magazine liver disease, 2000, 8(6): 324-329.
|
7. |
Chinese chemical fiber liver Institute of liver disease. Clinical assessment and diagnosis of liver fibrosis consensus. Chinese magazine liver disease, 2002, 10(5): 327-328.
|
8. |
Quan QZ, Sun ZQ, Wang YJ, editor in chief. New Liver Diseases. JiLan: Shandong Science and Technology Press, 2003, 338.
|
9. |
Luo JW, Shao JH, Bai J, et al. Transient elastography imaging for the non-invasive evaluation of liver fibrosis. Chinese magazine liver disease, 2006, 14(5): 395-397.
|
10. |
王宝恩, 张定凤 主编. 现代肝脏病学. 第1版. 北京: 科学出版社, 2003, p. 513.
|
11. |
骆抗先. 主编. 乙型肝炎-基础和临床. 第一版. 北京: 人民卫生出版社, 1997, p. 370.
|
12. |
朗江明. 主编. 临床免疫诊断学. 第一版. 广州: 广东科技出版社, 2003, p. 61.
|
13. |
http://www.beixi.com/cn/the.htm.
|
14. |
王宝恩. 当前肝纤维化研究的若干动向. 中华肝脏病杂志, 2006, 14(3): 167~168.
|
15. |
1995年5月北京第五次全国传染病寄生虫病学术会议讨论修订. 病毒性肝炎防治方案(试行) . 中华传染病杂志, 1995, 13(4): 241~247.
|
16. |
Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol, 1991, 13: 372.
|
17. |
Halfon P,Bourliere M, Penaranda G, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comparative hepatology, 2005, 4:6 dio: 10.1 186/1476-5926-4-6.
|
18. |
Montazeri G, Estakhri A, Mohamadnejad M, et al. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HbeAg-negative chronic hepatitis B. BMC gastroenterology , 2005; 5:32 doi:10.1 186/1471-230×/5/32.
|
19. |
Plevris JN, Haydon GH, Simpson KJ, et al. Serum hualuronan-a non-invasive test for diagnosing liver cirrhosis. European journal of gastroenterology&hepatology, 2000, 12:1121-1127.
|
20. |
Desmet Murawaki Y, Iknta Y, Koda M, et al. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. Journal of gastroenterology and hepatoloigy, 1996, 11: 459-465.
|
21. |
中华肝脏病学会肝纤维化学组. 肝纤维化诊断及疗效评估共识. 中华肝脏病杂志, 2002, 10(5): 327~328.
|
22. |
Lichtinghagen R, Bahr M. Noninvasive diagnosis of fibrosis in chronic liver disease . Expert. Rev. Mol. Diagn. 2004, 4(5): 715-726.
|
23. |
权启镇, 孙自勤, 王要军. 主编. 新肝脏病学. 济南: 山东科技出版社, 2003, 338.
|
24. |
Wang BE. 16 Kelleher TB, Mehta SH, Bhaskar R, et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. Journal of hepatology, 2005, 43: 78-84.
|
25. |
Patel K, Gordon SC, Jacobson I, et al. Evaluation of a panel of non-invasive serum marders to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. Journal of hepatology, 2004, 41: 935-942.
|
26. |
Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study . Lancet, 2001, 357(9262): 1069-1075.
|
27. |
Forns X, Ampurdancs S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, 2002, 36(4): 986-992.
|
28. |
Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003, 38(2): 518-526.
|
29. |
Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology, 1988, 95(3): 734-739.
|
30. |
Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterolohy, 2005, 128: 343-350.
|
31. |
罗建文, 邵金华, 白净, 等. 瞬时弹性成像用于肝纤维化的无创评价. 中华肝脏病杂志, 2006, 14(5): 395~397.
|
32. |
Poynard T, Munteanu M, Imbert-Bismut F, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clinical chemistry, 2004, 50(8): 1344-1355.
|
33. |
Olga OZ, Nikolai DY. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements? Current pharmaceutical biotechnology, 2003, 4: 195-209.
|
34. |
Afdhal NH, Evaluation of liver fibrosis: a concise review. American journal of gastroenterology, 2004, 1160-1174.
|
35. |
年9月西安中华医学会传染病与寄生虫病学分会、肝病学分会联合修订. 病毒性肝炎防治方案. 中华肝脏病杂志, 2000, 8(6): 324~329.
|